Parkinson hastalığında levodopa ile ilgili dalgalanmaların spektrumu.
The spectrum of levodopa-related fluctuations in Parkinson's disease.
DOI: 10.1212/wnl.43.8.1459PMID: 8350996
The spectrum of levodopa-related fluctuations in Parkinson's disease.
DOI: 10.1212/wnl.43.8.1459PMID: 8350996
Suppression of dyskinesias in advanced Parkinson's disease. I. Continuous intravenous levodopa shifts dose response for production of dyskinesias but not for relief of parkinsonism in patients with advanced Parkinson's disease.
DOI: 10.1212/wnl.43.8.1545PMID: 8351009
Suppression of dyskinesias in advanced Parkinson's disease. II. Increasing daily clozapine doses suppress dyskinesias and improve parkinsonism symptoms.
DOI: 10.1212/wnl.43.8.1551PMID: 8043043
Phenotypic expression of X-linked dystonia-parkinsonism (lubag) in two women.
DOI: 10.1212/wnl.43.8.1555PMID: 8351010
Comparison of striatal 18F-dopa uptake in adult-onset dystonia-parkinsonism, Parkinson's disease, and dopa-responsive dystonia.
DOI: 10.1212/wnl.43.8.1563PMID: 8351012
Asymmetrical pre-synaptic and post-synpatic changes in the striatal dopamine projection in dopa naïve parkinsonism. Diagnostic implications of the D2 receptor status.
DOI: 10.1093/brain/116.4.853PMID: 8353712
Response choice in Parkinson's disease. The effects of uncertainty and stimulus-response compatibility.
DOI: 10.1093/brain/116.4.869PMID: 8353713
Alternating fluency in Parkinson's disease. An evaluation of the attentional control theory of cognitive impairment.
DOI: 10.1093/brain/116.4.887PMID: 8353714
Application of Hick's law of response speed in Alzheimer and Parkinson diseases.
DOI: 10.2466/pms.1993.77.1.107PMID: 8367225
Symptomatic anti-parkinsonian effects of monoamine oxidase-B inhibition: comparison of selegiline and lazabemide.
DOI: 10.1097/00002826-199308000-00005PMID: 8374913
Parkinson's disease: past, present, and future.
DOI: 10.1038/npp.1993.39PMID: 8397719
Comparisons of therapeutic effects of levodopa, levodopa and selegiline, and bromocriptine in patients with early, mild Parkinson's disease: three year interim report. Parkinson's Disease Research Group in the United Kingdom.
DOI: 10.1136/bmj.307.6902.469PMID: 8400928
Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.